| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active-specific immunization against melanoma: Is the problem at the receiving end?
|
Monsurrò, Vladia
|
|
2003
|
13 |
6 |
p. 473-480
8 p.
|
artikel
|
| 2 |
Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine
|
Hsueh, Eddy C
|
|
2003
|
13 |
6 |
p. 401-407
7 p.
|
artikel
|
| 3 |
Dendritic cells as vectors for immunotherapy of cancer
|
Paczesny, Sophie
|
|
2003
|
13 |
6 |
p. 439-447
9 p.
|
artikel
|
| 4 |
Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration
|
Andersen, Mads Hald
|
|
2003
|
13 |
6 |
p. 449-459
11 p.
|
artikel
|
| 5 |
Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells
|
Speiser, Daniel E.
|
|
2003
|
13 |
6 |
p. 461-472
12 p.
|
artikel
|
| 6 |
Immunotherapy of melanoma
|
Parmiani, Giorgio
|
|
2003
|
13 |
6 |
p. 391-400
10 p.
|
artikel
|
| 7 |
Immunotherapy of melanoma: the good news, the bad ones and what to do next
|
Marincola, Francesco M.
|
|
2003
|
13 |
6 |
p. 387-389
3 p.
|
artikel
|
| 8 |
Local delivery of poxvirus vaccines for melanoma
|
Hörig, Heidi
|
|
2003
|
13 |
6 |
p. 417-422
6 p.
|
artikel
|
| 9 |
Peptide vaccine trials for melanoma: preclinical background and clinical results
|
Talebi, Tony
|
|
2003
|
13 |
6 |
p. 431-438
8 p.
|
artikel
|
| 10 |
Rational peptide-based tumour vaccine development and T cell monitoring
|
Scheibenbogen, Carmen
|
|
2003
|
13 |
6 |
p. 423-429
7 p.
|
artikel
|
| 11 |
Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®
|
Sondak, Vernon K
|
|
2003
|
13 |
6 |
p. 409-415
7 p.
|
artikel
|
| 12 |
Volume Contents, Author and Keyword Indexes
|
|
|
2003
|
13 |
6 |
p. I-XI
nvt p.
|
artikel
|
Tijdschrift beschrijving